Check out the toolkit and get ready to share using #ThxBirthControl!
Educational MaterialsGet patient educational materials, the kind they'll actually read.
Tearsheets, postcards, and posters with just the right amount of information. Order now from the Power to Decide store.
NewsletterSign up for our newsletter
You'll stay on top of everything that's happening with Bedsider Providers and get a discount on our best materials including t-shirts, posters, tear sheets, DVDs, and more!
Unique challenges to accessing and opportunities for improved integration of sexual and reproductive health care.
A practical guide for providers to provide trauma-informed physical examinations.
What providers need to know to answer patients' questions about OTC birth control pills.
Initial reports from the ongoing narrative collection Care Post Roe documenting poor-quality care, patient perspectives on telehealth medication abortion, adolescent preferences and experiences with pregnancy options counseling, and more.
Pain management in abortion care, risk of Rh sensitization with abortion before 12 weeks’ gestation, contraception information on TikTok, and more.
COX-2 inhibitor demonstrates potential in increasing efficacy of OTC LNG-EC pills; updated systematic review and meta-analysis supporting the effectiveness and safety of misoprostol-alone for medication abortion; support needs of adolescents and young adult abortion seekers; and more!
Men’s willingness to use novel birth control, characteristics of patients seeking telehealth medication abortion care, mifepristone as a potential treatment for adenomyosis, and the impact of the pill on adolescent bone health.
What providers need to know about how to screen, what to look for, and what to do next.
Answers for pharmacists (and other providers) about the current status of getting mifepristone at a pharmacy.
What providers need to know about the December 2022 updates to levonorgestrel emergency contraception (LNG-EC) labeling.
Providers are a critical link for abortion seekers.
Perceived pain and sedation dosing during abortion procedures by demographics, PAPP-A as a novel screening for gestational age before medication abortion, patient experiences with progestin-only pills and attitudes towards OTC access.
Patients' preferences for contraceptive educational materials, management of missing IUD strings and migrated IUDs, and providers’ perspectives on how to improve contraceptive counseling.
Continued support for misoprostol-only regimens for medication abortion and self-managed abortion between nine and 16 weeks gestation, the use of home pregnancy tests for follow-up care after a telehealth medication abortion, where adolescents and young adults go online to get abortion information, and disparities in recommended retesting for women with trichomonas vaginalis infections.
What providers need to know for counseling patients and managing their pain during IUD insertion.